Format

Send to

Choose Destination
Biochem Soc Trans. 2011 Apr;39(2):431-6. doi: 10.1042/BST0390431.

mTOR Signalling in Health and Disease.

Author information

1
School of Biological Sciences, Life Sciences Building, University of Southampton, Southampton SO17 1BJ, UK. C.G.Proud@soton.ac.uk

Abstract

The TOR (target of rapamycin) proteins are found in all eukaryotes. TOR has a protein kinase domain, as well as other domains through which it interacts with partner proteins to form at least two types of multiprotein complex, TORC1 and TORC2 (TOR complexes 1 and 2). Rapamycin, an antibiotic and immunosuppressant, inhibits functions of TORC1. Use of this drug has revealed roles for TORC1 and its mammalian counterpart, mTORC1, in promoting many anabolic processes. mTORC1 signalling is activated by growth factors and nutrients. It is highly active in many cancers and plays a role in tumorigenesis and in other diseases. Much less is known so far about the functions and regulation of (m)TORC2. The goal of this meeting was to bring together researchers studying the roles of mTORC1/2 in normal cell and animal physiology in diverse systems, as well as scientists exploring the therapeutic value of inhibiting mTOR (mammalian TOR) signalling.

PMID:
21428914
DOI:
10.1042/BST0390431
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center